Related Experiment Video
Updated: Aug 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Levels of H-ras codon 61 CAA to AAA mutation: response to 4-ABP-treatment and Pms2-deficiency
Barbara L Parsons1, Robert R Delongchamp, Frederick A Beland
1Division of Genetic and Reproductive Toxicology, Division of Biometry and Risk Assessment and Division of Biochemical Toxicology, National Center for Toxicological Research, USFDA, Jefferson, AR 72079, USA. bparsons@nctr.fda.gov
Abstract:
DNA mismatch repair (MMR) deficiencies result in increased frequencies of spontaneous mutation and tumor formation. In the present study, we tested the hypothesis that a chemically-induced mutational response would be greater in a mouse with an MMR-deficiency than in the MMR-proficient mouse models commonly used to assay for chemical carcinogenicity. To accomplish this, the induction of H-ras codon 61 CAA-->AAA mutation was examined in Pms2 knockout mice (Pms2-/-, C57BL/6 background) and sibling wild-type mice (Pms2+/+). Groups of five or six neonatal male mice were treated with 0.3 micromol 4-aminobiphenyl (4-ABP) or the vehicle control, dimethylsulfoxide. Eight months after treatment, liver DNAs were isolated and analysed for levels of H-ras codon 61 CAA-->AAA mutation using allele-specific competitive blocker-PCR. In Pms2-proficient and Pms2-deficient mice, 4-ABP treatment caused an increase in mutant fraction (MF) from 1.65x10(-5) to 2.91x10(-5) and from 3.40x10(-5) to 4.70x10(-5), respectively. Pooling data from 4-ABP-treated and control mice, the approximately 2-fold increase in MF observed in Pms2-deficient as compared with Pms2-proficient mice was statistically significant (P=0.0207) and consistent with what has been reported previously in terms of induction of G:C-->T:A mutation in a Pms2-deficient background. Pooling data from both genotypes, the increase in H-ras MF in 4-ABP-treated mice, as compared with control mice, did not reach the 95% confidence level of statistical significance (P=0.0606). The 4-ABP treatment caused a 1.76-fold and 1.38-fold increase in average H-ras MF in Pms2-proficient and Pms2-deficient mice, respectively. Furthermore, the levels of induced mutation in Pms2-proficient and Pms2-deficient mice were nearly identical (1.26x10(-5) and 1.30x10(-5), respectively). We conclude that Pms2-deficiency does not result in an amplification of the H-ras codon 61 CAA-->AAA mutational response induced by 4-ABP.
Insights
DNA mismatch repair (MMR) deficiencies do not amplify chemically induced mutations. This study found Pms2-deficient mice did not show a greater mutational response to 4-aminobiphenyl (4-ABP) than MMR-proficient mice.
Area of Science:
- Genetics
- Molecular Biology
- Toxicology
Background:
- DNA mismatch repair (MMR) deficiencies are linked to increased mutation rates and tumor formation.
- MMR-proficient mouse models are standard for assessing chemical carcinogenicity.
- Pms2 is a key protein in the MMR pathway.
Purpose of the Study:
- To investigate if MMR deficiency enhances chemically induced mutations.
- To compare the mutational response to 4-aminobiphenyl (4-ABP) in Pms2-deficient versus Pms2-proficient mice.
- To determine if Pms2 deficiency amplifies H-ras codon 61 mutations.
Main Methods:
- Utilized Pms2 knockout (Pms2-/-) and wild-type (Pms2+/+) mice.
- Neonatal mice were treated with 4-aminobiphenyl (4-ABP) or vehicle control.
- Liver DNA was analyzed for H-ras codon 61 CAA-->AAA mutations using allele-specific competitive blocker-PCR.
Main Results:
- 4-ABP treatment increased mutant fraction (MF) in both Pms2-proficient and Pms2-deficient mice.
- The fold-increase in MF from 4-ABP was similar in both genotypes (1.76-fold vs. 1.38-fold).
- Induced mutation levels were nearly identical between Pms2-proficient and Pms2-deficient mice.
Conclusions:
- Pms2 deficiency does not amplify the H-ras codon 61 CAA-->AAA mutational response induced by 4-ABP.
- The study hypothesis that MMR deficiency would amplify chemically induced mutations was not supported for this specific mutation and chemical.
- Findings suggest MMR status may not universally amplify all chemically induced mutational responses.
Related Concept Videos
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutations
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Leaky Scanning
